Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Kidney & Blood Pressure Research|December 24, 2003
Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysisJolanta Małyszko, Jacek S Małyszko, Michał Myśliwiec
Kidney & Blood Pressure Research|November 9, 2002
Some aspects of hemostasis in CAPD patients treated with erythropoietinJolanta Małyszko, Ewa Suchowierska, Jacek S Małyszko, et al.
Annals of Transplantation|September 12, 2002
Effects of immunosuppressive drugs on platelet aggregation in vitroJolanta Małyszko, Jacek S Małyszko, Akikazu Takada, et al.
Thrombosis and Haemostasis|February 26, 2004
Thrombin activatable fibrinolysis inhibitor (TAFI) and markers of endothelial cell injury in dialyzed patients with diabetic nephropathyJolanta Małyszko, Jacek S Małyszko, Tomasz Hryszko, et al.
Polskie Archiwum Medycyny Wewnetrznej|December 20, 2003
[Thrombin activatable fibrinolysis o inhibitor-TAFI- in dialyzed patients with diabetic nephropathy]Jacek S Małyszko, Jolanta Małyszko, Tomasz Hryszko, et al.
American Journal of Nephrology|March 22, 2006
Apelin and cardiac function in hemodialyzed patients: possible relations?Jolanta Małyszko, Jacek S Małyszko, Piotr Koźminski, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 1, 2009
Structural changes in carotid arteries and impairment of fibrinolysis in hemodialyzed and peritoneally dialyzed patientsJolanta Małyszko, Urszula Łebkowska, Jacek S Małyszko, et al.
Archives of Medical Science : AMS|March 16, 2012
Serum neutrophil gelatinase-associated lipocalin as a marker of kidney function in pregnancy - useful or doubtful?Jacek S Małyszko, Leszek Rams, Lena Drozdowska-Rams, et al.
Journal of Clinical Medicine|March 14, 2026
IgA Nephropathy: Epidemiology, Outcomes, and Insights for Primary GlomerulonephritidesZuzanna Jakubowska, Filip Wantoch-Rekowski, Jacek S Małyszko, et al.
Pageof 3